Journal of Medicinal Chemistry · 2020 · 14 citations · 51 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DesignDrug DiscoveryNatural Product Drug DiscoveryNatural Product-based Drug DesignStructure-activity Relationship AnalysisAnticancer ActivityAntiproliferative AgentsAntiproliferative Drug ActionBiological Evaluation ReportChemical Synthesis Of AnaloguesIn Vivo StudiesPreclinical Drug DevelopmentProfiling
studies with archazolids, complex polyketide macrolides, which present the most potent V-ATPase inhibitors known to date. Herein, we report a biomimetic, one-step preparation of archazolid F, the most potent and least abundant archazolid, the design and synthesis of five novel, carefully selected archazolid analogues, and the biological evaluation of these antiproliferative agents, leading to the discovery of a very potent but profoundly simplified archazolid analogue. Furthermore, the first general biological profiling of the archazolids against a broad range of more than 100 therapeutically relevant targets is reported, leading to the discovery of novel and important targets. Finally, first pharmacokinetic data of these natural products are disclosed. All of these data are relevant in the further preclinical development of the archazolids as well as the evaluation of V-ATPases as a novel and powerful class of anticancer targets.
51
Gregory R. Fulmer, Alexander J. M. Miller, Nathaniel H. Sherden et al. · Organometallics · 2010 · 3.9K citations
The v-ATPase V 0 Subunit a1 Is Required for a Late Step in Synaptic Vesicle Exocytosis in Drosophila
P. Robin Hiesinger, Amir Fayyazuddin, Sunil Mehta et al. · Cell · 2005 · 298 citations · Full text
Life Sciences, Biology, Neuroscience +16
From Lysosomes to the Plasma Membrane
Takao Toyomura, Yoshiko Murata, Akitsugu Yamamoto et al. · Journal of Biological Chemistry · 2003 · 273 citations · Full text